ADMP - Adamis Pharmaceuticals Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts3033
Avg. Estimate-0.190-0.89-0.57
Low Estimate-0.220-0.93-0.69
High Estimate-0.160-0.86-0.43
Year Ago EPS-0.24-0.23-0.9-0.89
Revenue EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts3333
Avg. Estimate5.47M5.63M16.39M27.82M
Low Estimate4.24M4.74M15.17M24.08M
High Estimate7.4M6.45M18.3M30.69M
Year Ago Sales2.84M3.18M13.07M16.39M
Sales Growth (year/est)92.50%77.10%25.40%69.70%
Earnings History12/30/20173/30/20186/29/20189/29/2018
EPS Est.-0.15-0.19-0.19-0.17
EPS Actual-0.24-0.23-0.29-0.21
Difference-0.09-0.04-0.1-0.04
Surprise %-60.00%-21.10%-52.60%-23.50%
EPS TrendCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Current Estimate-0.190-0.89-0.57
7 Days Ago-0.18-0.17-0.89-0.55
30 Days Ago-0.11-0.11-0.81-0.38
60 Days Ago-0.09-0.06-0.74-0.37
90 Days Ago-0.09-0.09-0.74-0.37
EPS RevisionsCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1N/A11
Growth EstimatesADMPIndustrySectorS&P 500
Current Qtr.20.80%N/AN/A0.46
Next Qtr.N/AN/AN/A0.29
Current Year1.10%N/AN/A0.20
Next Year36.00%N/AN/A0.08
Next 5 Years (per annum)N/AN/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A